Unique ID issued by UMIN | UMIN000004962 |
---|---|
Receipt number | R000005903 |
Scientific Title | Study of efficacy and tolerability of combination therapy with palonosetron and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting in patients with cervical cancer. |
Date of disclosure of the study information | 2011/02/01 |
Last modified on | 2018/08/11 06:37:54 |
Study of efficacy and tolerability of combination therapy with palonosetron and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting in patients with cervical cancer.
Study of efficacy and tolerability of combination therapy with palonosetron and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting in patients with cervical cancer.
Study of efficacy and tolerability of combination therapy with palonosetron and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting in patients with cervical cancer.
Study of efficacy and tolerability of combination therapy with palonosetron and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting in patients with cervical cancer.
Japan |
Cervical cancer
Obstetrics and Gynecology |
Malignancy
NO
We evaluate the efficacy and tolerability of a combination therapy with palonosetron and dexamethasone in patients receiving the chemotherapy with nedaplatin and irinotecan.
Safety,Efficacy
Confirmatory
Pragmatic
Phase II
The proportion of patients with complete response (CR: no vomiting and no use of rescue therapy ) in the delayed phase (24-120 hour after administration of nedaplatin and irinotecan)
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
palonosetron 0.75mg (day 1) (iv)
20 | years-old | < |
Not applicable |
Female
# 20 Years and older
# Cervical cancer
# Patients with received the combination therapy with nedaplatin and irinotecan
# Adequate organ function for enrollment
# Performance Status : 0-2
# Patients with written informed consent
# They had serious complication.
(intestinal paralysis, lung fibrosis, diabetes mellitus, heart failure, myocardial infarction, angina pectoris, renal failure, psychiatric disorder, cerebrovascular accident, active gastric ulcer, active duodenal ulcer)
# No known CNS metastasis
# Patients who has a convulsive disorders that need anticonvulsants therapy
# They had ascites or pleural effusion needs paracentesis treatment
# Patients with obstruction of gastrointestinal tract,for example gastric outlet or ileus
# Patients with vomiting or nausea (>= Grade2)
# Hypersensitivity or severe drug allergy for Aloxi or other 5-HT3RA
# Hypersensitivity or severe drug allergy for dexamethasone
# Pregnant, breastfeeding or expecting woman
# Patients judged inappropriate for this study by physicians
40
1st name | |
Middle name | |
Last name | Ikuo Konishi |
Kyoto University Graduate School of Medicine
Gynecology and Obstetrics
54 Shogoinkawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan
0757513269
babatsu@kuhp.kyoto-u.ac.jp
1st name | |
Middle name | |
Last name | Masafumi Koshiyama |
Kyoto University Graduate School of Medicine
Gynecology and Obstetrics
54 Shogoinkawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan
0757513269
babatsu@kuhp.kyoto-u.ac.jp
Kyoto University Graduate School of Medicine
none
Self funding
NO
2011 | Year | 02 | Month | 01 | Day |
Published
https://www.medscimonit.com/download/index/idArt/899741
Completed
2011 | Year | 01 | Month | 17 | Day |
2011 | Year | 02 | Month | 01 | Day |
2012 | Year | 12 | Month | 01 | Day |
2011 | Year | 01 | Month | 26 | Day |
2018 | Year | 08 | Month | 11 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005903